CD4 and HIV-1 infection: Recently, CRISPR/Cas9 system as a novel method of gene editing was used to disrupt CCR5 in T cell lines, primary CD4+ T cells, or induced pluripotent stem cells (iPSCs) to make them or their progeny cells resistant to HIV-1 infection [63–65].